Pharmafile Logo

Cuttsy+Cuttsy launch their latest patient e-book

On the eve of ‘World Osteoporosis Day’ (worldosteoporosisday.org), Cuttsy+Cuttsy are proud to launch their latest e-book ‘Osteoporosis…in plain English’.

Osteoporosis is a chronic condition that affects up to one in three people aged 50 and over. But as a silent condition, many people may not be aware they have osteoporosis until they experience a fracture and pain.

Written by Scientific Team Leader Dr Liz Walder, and beautifully illustrated by Graphic Designer Kiemia Farrow, Osteoporosis … in plain English’ provides accessible information for anyone who wants to understand more about osteoporosis and its treatment.

- PMLiVE

As with other titles in Cuttsy+Cuttsy’s ‘in plain English’ series, this not-for-profit book has been created with health literacy principles in mind, and it has been reviewed by the people who matter most – patients.   ‘Osteoporosis… in plain English’ serves as a comprehensive, easy-to-understand resource to help people better understand a debilitating condition that can have a big impact on quality of life.

If you or someone you know has osteoporosis, this book might help take some of the unknown away. You can purchase a copy of ‘Osteoporosis…in plain English’ through Amazon, along with the other titles in the series:
- PMLiVE

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

New report now available: Integrating ‘patient first’ into medicine development

A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...

The digital prescription – enhancing the patient experience with technology

We explore how digital health innovations are revolutionising patient care by enhancing accessibility, personalisation, and engagement, promising a more connected and empowered patient experience.

Compliance — a driving force for influencing public perceptions of the pharma industry?

How does compliance play into public perceptions of pharma and why is it important for improving public opinion?

Another year, another B!

Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Clinical trial considerations: Why supporting HCPs matters…

When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

Clinical trial considerations: Why diversity matters…

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...

Clinical trial considerations: Why digital matters…

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

Clinical trials explained: Why imagery matters…

Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...

Clinical trials explained: Why health literacy matters…

Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...